OSU Medical Center News & Notes

Entries tagged as ‘innovation’

Research Means Hope Today and Every Day

October 21, 2009 · 1 Comment

Add to FacebookAdd to NewsvineAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Furl

National Medical Research Day is today, October 21, 2009.  Ohio State Medical Center will gather to honor researchers between 4 pm and 6 pm today.  We’ll post pictures and video from patients who are being cured by research funded by the NIH and talk to researchers in the trenches trying to answer questions about cancer, heart health, autism and others.
Please share your story about how research has touched your life by adding comments below.

If you are interested in learning more about how to get involved in advocacy for research, New Voices for Research is a great place to start.

Release from Research Means Hope:

Leaders from the nation’s medical schools and teaching hospitals, scientific community, universities, patient community and industry organizations gathered today in honor of “National Medical Research Day” to thank the Obama Administration, Congress, and American taxpayers for the medical research funding included in the American Recovery and Reinvestment Act, and to urge approval of significant, annual budget increases for the National Institutes of Health (NIH) to sustain the momentum created by these funds.

“Medical research is the road to recovery, both for our nation’s physical as well as fiscal health,” said Edward Miller, M.D., dean and CEO of Johns Hopkins University and chair of the ResearchMeansHope.org campaign, the sponsor of today’s press conference. “The nation’s medical research community is extremely grateful for this unprecedented infusion of funds for NIH research, which will not only create jobs, but will, over time, improve and even save lives.”

ResearchMeansHope.org is a campaign to raise public awareness of the critical need for sustained growth in federal funding for medical research.  This effort is sponsored by the Association of American Medical Colleges, the Association of American Universities, the Association of Public and Land-grant Universities, the Federation of American Societies for Experimental Biology, the Johns Hopkins University, and more than 40 other organizations.

In addition to thanking the Administration and Congress for the Recovery Act funding, participants at today’s press conference also called on the president to fulfill his promise of making medical research a key pillar of the nation’s long-term economic growth strategy as the administration prepares its budget priorities for 2011.

The Recovery Act includes $10.4 billion in funding for NIH.  To date, more than $4 billion has been awarded, generating nearly 13,000 new grants to support the full continuum of medical research.  According to White House estimates, this funding will create tens of thousands of jobs over the next two years.

“This is a huge boost for the research community, for investigators at all stages of their careers,” said Judith S. Bond, Ph.D., M.S., Distinguished Professor and Chair, Department of Biochemistry and Molecular Biology at The Pennsylvania State University College of Medicine. “After six years of virtually flat NIH funding, these funds will allow the research community to explore important, innovative new ideas.”

“Every American suffering from disease understands that research means hope on a very basic level,” says Billy Tauzin, president and CEO of Pharmaceutical Research and Manufacturers of America (PhRMA). “We are proud to join with Research Means Hope coalition and applaud President Obama and Congress’ efforts to increase NIH research funding while urging that even more be done.  Combined, the medical research supported by the NIH, medical schools and its affiliates, as well as research laboratories of pharmaceutical and biotech companies across America hold real promise in the search for new treatments and even more cures for diseases that patients throughout the world hope for.”

NIH-funded research has helped millions of Americans lead longer, healthier lives.  For example, over the past 30 years there has been a 50 percent decline in deaths from heart disease and a 60 percent decline in deaths from stroke.  NIH-funded advances have led to a vaccine to prevent cervical cancer, improved treatments for asthma and near-elimination of mother-to-child HIV transmission.  This and other research offers hope for those facing serious diseases such as cancer, Alzheimer’s, depression, and Parkinson’s. NIH funding also supports the nation’s economic health by creating skilled jobs and new products that lead to long-term economic growth.

Patients speaking at the conference underscored the benefits of NIH research. Twelve-year old Chloe Lamprecht, a volunteer with the American Diabetes Association, JDRF and the University of Nebraska Medical Center, was diagnosed with Type 1 diabetes in November 2004.  In recent years, diabetes research has led to a number of advances including development of quick-acting and long-acting insulins and an external insulin pump to replace daily injections.

“Living with Type 1 Diabetes is very challenging.  I never get a day off from the disease,” said Chloe.  “My hope is for a cure, but until a cure is found I hope that researchers will find better ways to help me manage my diabetes.”

Olivia Grace Jones was diagnosed at six months with idiopathic dilated cardiomyopathy.  Today she is an energetic five year old with a new heart thanks to advances in surgery, transplant technologies, medical equipment progress and advances in pharmaceuticals.  She and her parents Schonay Barnett-Jones and Kevin Jones, are volunteers for the American Heart Association

“My family understands the wonderful benefits that are gained from medical research.  Twenty years ago Olivia’s outcome could have been very different,” said Barnett-Jones.  “But, today because of advances in pediatric cardiac research specifically, our little girl is growing and thriving and dreaming of being a zoo keeper.  What more could any parent ask for?”

For more information on ResarchMeansHope.org and the many benefits of NIH-supported research, visit www.ResearchMeansHope.org.  To become a friend of the campaign, on Facebook, visit http://facebook.com/pages/Research-Means-Hope/83176136398. To follow the effort on Twitter, go to http://twitter.com/researchhope.

Add to FacebookAdd to NewsvineAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Furl

Categories: Medical Center News · Research/Innovation · Ross Heart Hospital · The James · University Hospital · personalized health care · personalized medicine
Tagged: , , , , ,

Ohio State To Pioneer National Genome Study

October 1, 2009 · Leave a Comment

Add to FacebookAdd to NewsvineAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Furl

Researchers at the Ohio State University Medical Center are partnering with one of the world’s most prestigious and leading biomedical research institutions, to provide personal genetic information to more than 100,000 people.

Ohio State’s Medical Center and the Coriell Institute for Medical Research, home of the world’s leading biobank resource for human cells and DNA, have officially announced their partnership in the Coriell Personalized Medicine Collaborative (CPMC). The personalized genetics study will involve an integrated approach to recruiting and enrolling 2,000 study participants at Ohio State, free of charge.

OSU Medical Center is one of only five centers in the country participating in the project with Coriell. Other participants will be enrolled at Fox Chase Cancer Center, Cooper University Hospital, Virtua Health and Helix Health. Study participants will also include volunteers from the Camden, N.J. community, where Coriell is headquartered.

Dr. Clay Marsh, executive director of Ohio State’s Center for Personalized Health Care

Dr. Clay Marsh, executive director of Ohio State’s Center for Personalized Health Care

“Through this collaboration, we will provide the unique opportunity for our community to participate in this ground-breaking national study and move toward wellness-based care that is predictive, preventive, personalized and participatory,” says Dr. Clay Marsh, executive director of Ohio State’s Center for Personalized Health Care.

“We are very excited for this opportunity for Ohio State to partner with the Coriell Institute and to help support their precedent setting study,” adds Marsh.

The Coriell Personalized Medicine Collaboration brings together doctors, patients, geneticists, counselors and information technology experts to create a protected environment for participants to see and understand their personal genomic information, and allow them to make individualized decisions about their health care. This platform will also enable health care providers to utilize the genetic-based information of participants to develop tailored medical and therapeutic treatments.

“Coriell recognizes the Ohio State University Medical Center’s established leadership in personalized healthcare and how this offers a unique setting for the CPMC research study,” says Dr. Michael Christman, president and C.E.O of the Coriell Institute.

“We are committed to creating the future of medicine to improve people’s lives through personalized healthcare,” Marsh adds. “Partnerships like this one will allow us and our community to experience the future of medicine today.”

Coriell Institute for Medical Research is a non-profit, biomedical research institution and the world’s leading biobank resource for human cells and DNA. Founded in 1953, the Coriell Institute conducts research on human genetic variation, mechanisms of cellular differentiation, and inherited genetic disorders. Visit http://cpmc.coriell.org for more information.

Add to FacebookAdd to NewsvineAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Furl

Categories: Medical Center News · Research/Innovation · personalized health care · personalized medicine
Tagged: , , , , , , , , , ,

Finding A Fix For America’s Obesity Problem

July 2, 2009 · Leave a Comment

Add to FacebookAdd to NewsvineAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Furl

Americans have some new insight into the obesity epidemic.  You may have seen or heard this story today in Central Ohio:
NBC 4
10TV
The Columbus Dispatch
 
4color_vert_medcenter_logoOr in the national media:
U.S. News & World Report-5 Lessons From the Nation’s Obesity Report Card
Forbes-Obesity Rates Continue to Climb in U.S.

Even WebMD, America’s go-to spot for consumer health information weighed in.

It’s estimated two out of three Americans are now overweight or obese – and spend about $60 billion a year to try and change it. But someday losing weight might be as quick as a single injection not in the arm but in the brain.

Add to FacebookAdd to NewsvineAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Furl

Categories: Medical Center News · Research/Innovation · personalized health care
Tagged: , , , , , , , , ,

What Does “Personalized Health Care” Mean to You?

June 10, 2009 · 4 Comments

Add to FacebookAdd to NewsvineAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Furl

-This is an identical copy of a post on the personal blog of Ryan Squire, the Program Director for Social Media at The OSU Medical Center.  There is very important conversation that must take place in order to shape the future of personalized health care and we need to start that conversation today.

This morning, I had the pleasure of attending a presentation given by Clay Marsh, MD. and senior associate vice president for research in the Office of Health Sciences, vice dean for research in the College of Medicine and executive director of the OSU Center for Personalized Health Care.

marsh_clayDr. Marsh was giving a presentation about personalized health care. It’s a bit of an industry buzz word, and everyone wants to be a part of it, but the U.S. Department of Health & Human Services has a good summary here. (more…)

Categories: Research/Innovation · Social Media · personalized health care · personalized medicine
Tagged: , , , , , , , ,

Marsh Named To Top Research Post At OSU Medical Center

June 8, 2009 · 2 Comments

COLUMBUS, Ohio – Dr. Clay Marsh (43221), an internationally respected Ohio State University scientist and educator, has been named to lead OSU Medical Center’s pioneering research program, one of the largest in the nation. In addition, he will direct the Medical Center’s innovative program for personalized health care.

Clary Marsh, MD. named to top research post at OSU Medical Center

Clary Marsh, MD. named to top research post at OSU Medical Center


The OSU Board of Trustees approved Friday (6/5) Marsh’s appointments as senior associate vice president for research in the Office of Health Sciences, vice dean for research in the College of Medicine and executive director of the OSU Center for Personalized Health Care.

Marsh has been on the medical staff at Ohio State since 1985 and most recently, as its director, helped elevate the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine to a position of national prominence. He also serves as director of the Center for Critical Care and Respiratory Medicine.

In his new roles he will lead planning and expansion of OSU Medical Center’s myriad research endeavors, which from 2000-2008 increased in funding by more than $120 million to $199.4 million.

Marsh also will be responsible for recruitment of key researchers and lead the introduction of advanced technology initiatives to the Medical Center.

Marsh will actively advance the Medical Center’s growing reputation as an international leader in personalized health care, a field that utilizes genetic-based information to develop tailored medical treatments.

The treatments can be adapted for individuals and focus on transforming medicine from a reactive, population and disease-based approach, to the practice of proactive, personalized and wellness-based medicine.

In making the appointments, Dr. Steven Gabbe, senior vice president for Health Sciences and CEO of OSU Medical Center, said Marsh is an exceptional person in all respects.

“Clay is one of Ohio State’s best examples of a top performer,” said Gabbe. “He excels as a scientist, clinician, teacher and administrator, and he has the ability to lead people and programs to their highest levels.

“With Clay’s leadership the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine has become the benchmark for similar programs around the country,” added Gabbe. In recent years, the program has been ranked consistently among America’s best by U.S. News & World Report magazine.

Marsh has won numerous teaching awards and has been recognized nationally for his research and devotion to teaching and mentorship of medical students, residents and fellows.

He has published more than 230 journal articles, abstracts and book chapters, and holds one patent with five more pending. He is associate editor of the Journal of Investigative Medicine and the American Journal of Physiology.

He also has served as chairman of the board of the Stanley Sarnoff Research Foundation and as a national leader in pulmonary medicine on the Battelle Bioinitiative in Pulmonary Medicine.

He earned his medical degree from West Virginia University and completed his residency in internal medicine at Ohio State, where he served as chief resident.
add to del.icio.us :: Add to Blinkslist :: add to furl :: Digg it :: add to ma.gnolia :: Stumble It! :: add to simpy :: seed the vine :: :: :: TailRank :: post to facebook

Categories: Medical Center News · Research/Innovation
Tagged: , , ,